Holocene Advisors, LP Lantheus Holdings, Inc. Transaction History

Holocene Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $25.8 Million - $44.8 Million	540,717 New	540,717 $44.6 Million
Q3 2021 Nov 15, 2021	SELL	$24.23 - $28.59 $1.29 Million - $1.53 Million	-53,341 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.51 - $27.64 $832,901 - $1.18 Million	42,691 Added 400.85%	53,341 $1.47 Million
Q1 2021 May 17, 2021	BUY	$13.77 - $21.66 $146,650 - $230,679	10,650 New	10,650 $228,000

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.